About H.C. Wainwright & Co. H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across ...

H.C. Wainwright has recently reduced Cassava Sciences Inc (SAVA) stock to Neutral rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 8, 2024, H.C. Wainwright had ...

H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...

Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.61 which represents a slight increase of $0.02 or 0.44% from the prior close of $4.59. The stock opened at $4.59 and touched a low ...

In a report released today, Emily Bodnar from H.C. Wainwright maintained a Hold rating on Agenus (AGEN – Research Report). The company’s shares ...

The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...

In conclusion, H.C. Wainwright's analyst remains optimistic about Immunocore's prospects, underpinned by the potential of its diverse pipeline and upcoming clinical milestones. With a market ...

HC Wainwright reissued their buy rating on shares of Larimar Therapeutics (NASDAQ:LRMR – Free Report) in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a $15.00 target ...

Analysts at HC Wainwright issued their FY2024 EPS estimates for Exodus Movement in a report issued on Thursday, January 23rd. HC Wainwright analyst K. Dede forecasts that the company will post ...